Other Clinical Trial - Treatment Of Hot Flashes/Flushes In Postmenopausal

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Menopausal and Female Climacteric States Clinical Trial

Official title:
A Parallel-group, Double-blind, Randomized, Placebo-controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Two Doses of GSK232802 Administered Orally as Monotherapy for 12 Weeks in Healthy Postmenopausal Women With Moderate to Extremely Severe Vasomotor Symptoms

NCT number	NCT00604825
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 2
Start date	July 17, 2007
Completion date	July 23, 2008

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms